RA Prescribing potassium despite hyperkalemia: medication errors uncovered by linking laboratory and pharmacy information systems. Am J Med.
2000;109494- 497Link to Article
et al. Guided medication dosing for inpatients with renal insufficiency. JAMA.
2001;2862839- 2844Link to Article
DO Inpatient theophylline toxicity: preventable factors. Ann Intern Med.
1991;114748- 753Link to Article
M Drug dosage in patients with renal failure optimized by immediate concurrent feedback. J Gen Intern Med.
2001;16369- 375Link to Article
DR Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med.
1994;1542641- 2645Link to Article
JP Evaluation of a computer-assisted antibiotic-dose monitor. Ann Pharmacother.
1999;331026- 1031Link to Article
MJ Liver enzyme monitoring in patients treated with troglitazone. JAMA.
2001;286831- 833Link to Article
et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA.
1995;27429- 34Link to Article
RM Computerized medication monitoring system. Am J Hosp Pharm. 1976;331061- 1064
DS Factors related to errors in medication prescribing. JAMA.
1997;277312- 317Link to Article
DW Incidence and preventability of adverse drug events in nursing homes. Am J Med.
2000;10987- 94Link to Article
et al. Drug complications in outpatients. J Gen Intern Med.
2000;15149- 154Link to Article
et al. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol.
1999;47557- 564Link to Article
TD Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA.
1998;2791024- 1029Link to Article
President's Advisory Committee on Consumer Protection and Quality in Healthcare, Building the capacity to improve quality: investing in information systems. Quality First Better Health Care for All Americans. Silver Spring, Md Agency for Healthcare Research and Quality Publications Clearinghouse1998;chap 14.
et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA.
1998;2801311- 1316Link to Article
GD The clinical value of computerized information services: a review of 98 randomized clinical trials. Arch Fam Med.
1996;5271- 278Link to Article
TW Overview: cooperating for improvement. Jt Comm J Qual Improv. 1995;21573- 577
DM A framework for capturing clinical data sets from computerized sources. Ann Intern Med.
1997;127675- 682Link to Article
J Future directions for research in laboratory medicine: the findings of a Delphi survey of stakeholders. Clin Lab Manage Rev. 1998;12221- 230
MJ Information management: moving from test results to clinical information. Clin Leadersh Manag Rev. 2000;14296- 300
WG The changing role of the medical technologist from technologist to information specialist. Clin Leadersh Manag Rev. 2000;14285- 288
R The electronic medical record: implications for the laboratory. Clin Leadersh Manag Rev. 2000;14292- 295
MR Medication Errors. Washington, DC American Pharmaceutical Association1999;
JP Prevention of adverse drug events through computerized surveillance. Proc Annu Symp Comput Appl Med Care. 1992;437- 441
et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc.
1999;6313- 321Link to Article
Institute of Medicine, Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC National Academy Press2001;
JJ The use of an integrated clinical laboratory and pharmacy diabetes database to provide physician performance feedback in an IPA-model HMO. J Ambulatory Care Manage.
1998;2112- 23Link to Article
D Outpatient diagnostic errors: unrecognized hyperglycemia. Eff Clin Pract. 2002;511- 16
J Making patient care easier under multiple managed care plans. Fam Pract Manag. 1998;538- 4245- 4853
CCfor the American College of Physicians, Clinical guideline, part 2. Screening for thyroid disease: an update. Ann Intern Med.
1998;129144- 158Link to Article
et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ.
2000;321405- 412Link to Article
L A case series of hospitalized patients with elevated digoxin levels. Am J Med.
1998;105110- 115Link to Article
WMed Drug Prescribing in Renal Failure: Dosing Guidelines for Adults. 4th ed. Philadelphia, Pa ACP-ASIM1999;
V Effects of liver disease on pharmacokinetics: an update. Clin Pharmacokinet.
1999;37399- 431Link to Article
Centers for Disease Control and Prevention, Drug-induced liver injury: a national and global problem. Westfields Conference Center Chantilly, Va February 12-13, 2001Available at: http://www.fda.gov/cder/livertox/default.htm
. Accessed January 25, 2003.
et al. What proportion of common diagnostic tests appear redundant? Am J Med.
1998;104361- 368Link to Article
DW Appropriateness of antiepileptic drug level monitoring. JAMA.
1995;2741622- 1626Link to Article
D Total quality management and physicians' clinical decisions. JAMA.
1993;2692775- 2778Link to Article
JC Use and interpretation of statistical quality control charts. Int J Qual Health Care.
1998;1069- 73Link to Article
WC Statistical process control methods for expert system performance monitoring. J Am Med Inform Assoc.
1996;3258- 269Link to Article
DM Controlling variation in health care: a consultation from Walter Shewhart. Med Care.
1991;291212- 1225Link to Article
LV Changing clinical practice by improving systems: the pursuit of clinical excellence through practice-based measurement for learning and improvement. Qual Manage Health Care.
2000;91- 13Link to Article
MM Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med.
2000;3421266- 1271Link to Article
N Drug-induced liver disorders: implications for drug development and regulation. Drug Saf.
2001;24483- 490Link to Article
SK Digoxin toxicity and electrolytes: a correlative study. Acta Cardiol. 1983;38115- 123
RH Effect of chronic potassium depletion on digitalis-induced inotropy and arrhythmias. Cardiovasc Res.
1981;1598- 107Link to Article
WS Incidence of digoxin toxicity in outpatients. West J Med. 1994;161474- 478
R Medically useful criteria for analytic performance of laboratory tests. Am J Clin Pathol. 1985;83200- 205
EA Lessons from the glitazones: a story of drug development. Lancet.
2001;3571870- 1875Link to Article
DW Use and monitoring of "statin" lipid-lowering drugs compared with guidelines. Arch Intern Med.
2001;16153- 58Link to Article
JT Total testing process applied to therapeutic drug monitoring: impact on patients' outcomes and economics. Clin Chem. 1998;44370- 374
ES Automated monitoring of drug-test interactions. Clin Pharmacol Ther. 1978;2416- 21
DS Effects of Preanalytical Variables on Clinical Lab Tests. 2nd ed. Washington, DC American Assocation for Clinical Chemistry Press1997;
JJ A medication database: a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol.
1997;5313- 17Link to Article
K Linking patient medication data with laboratory information system. Int J Biomed Comput.
1996;42111- 116Link to Article
et al. Reminders of drug effects on laboratory test results. Clin Chem. 2000;461395- 1400
A Drug interference in clinical chemistry: recommendation of drugs and their concentrations to be used in drug interference studies. Ann Clin Biochem.
376- 385Link to Article
JJ Computerized monitoring of potentially interfering medication in thyroid function diagnostics. Int J Clin Monit Comput.
1997;14255- 259Link to Article
JJ Using computerized individual medication data to detect drug effects on clinical laboratory tests. Scand J Clin Lab Invest Suppl.
1995;22231- 36Link to Article
S The preanalytic phase: an important component of laboratory medicine. Am J Clin Pathol.
2000;113429- 452Link to Article
LA Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med.
2000;1602093- 2099Link to Article
et al. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol.
2000;50479- 484Link to Article
LE Surveillance for quality assessment, IV: surveillance using a hospital information system. Infect Control Hosp Epidemiol.
1991;12239- 244Link to Article
CJ Practice databases and their uses in clinical research. Stat Med.
1991;10541- 557Link to Article
SA A data mining system for infection control surveillance. Methods Inf Med. 2000;39303- 310
SA Association rules and data mining in hospital infection control and public health surveillance. J Am Med Inform Assoc.
1998;5373- 381Link to Article
WW The promise of human genetic databases. BMJ.
2001;3221009- 1010Link to Article
DW Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf.
2001;10113- 119Link to Article
et al. Computerized monitoring of valproate and physician responsiveness to laboratory studies as a quality indicator. Psychiatr Serv.
2000;511179- 1181Link to Article
MAvan der Lei
JH Assessment of decision support for blood test ordering in primary care: a randomized trial. Ann Intern Med.
2001;134274- 281Link to Article
JW Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes. Diabetes Care.
2000;231637- 1641Link to Article
et al. Performance status of health care facilities changes with risk adjustment of HbA1c. Diabetes Care.
2000;23919- 927Link to Article
Centers for Disease Control Diabetes in Managed Care Work Group, Diabetes mellitus in managed care: complications and resource utilization. Am J Manage Care. 2001;7501- 508
et al. Diabetes prevalence and hospital and pharmacy use in the Veterans Health Administration (1994): use of an ambulatory care pharmacy-derived database. Diabetes Care.
1998;21368- 373Link to Article
EA Evaluation of an imipenem/cilastatin target drug program. DICP. 1991;25348- 350
PM Identification of patients for pharmacologic review by computer analysis of clinical laboratory drug concentration data. Am J Clin Pathol. 1995;103710- 717
et al. Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory. Diagn Microbiol Infect Dis.
1993;16255- 264Link to Article
K Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA.
1998;2801339- 1346Link to Article
DW Effects of computerized physician order entry on prescribing practices. Arch Intern Med.
2000;1602741- 2747Link to Article
A Effects of computer-based clinical decision support systems on clinician performance and patient outcome: a critical appraisal of research. Ann Intern Med.
1994;120135- 142Link to Article
et al. Multicentre randomised study of computerised anticoagulant dosage: European Concerted Action on Anticoagulation. Lancet.
1998;3521505- 1509Link to Article
DW Evaluating the appropriateness of digoxin level monitoring. Arch Intern Med.
1999;159363- 368Link to Article
et al. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. Am J Med.
1999;106144- 150Link to Article
et al. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med.
1994;1541511- 1517Link to Article
et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA.
1998;2801317- 1320Link to Article
J Wireless clinical alerts for physiologic, laboratory and medicationdata. Proc AMIA Symp. 2000;789- 793
CJ A randomized trial of "corollary orders" to prevent errors of omission. J Am Med Inform Assoc.
1997;4364- 375Link to Article
T Reducing the frequency of errors in medicine using information technology. J Am Med Inform Assoc.
2001;8299- 308Link to Article
et al. How promptly are inpatients treated for critical laboratory results? J Am Med Inform Assoc.
1998;5112- 119Link to Article
JP Computerized surveillance of adverse drug events in hospital patients. JAMA.
1991;2662847- 2851Link to Article
et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc.
1998;5305- 314Link to Article
et al. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf.
2000;22161- 168Link to Article
et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc.
2001;8254- 266Link to Article
RM Computers, quality, and the clinical laboratory: a look at critical value reporting. Proc Annu Symp Comput Appl Med Care. 1993;193- 197
Not Available, Physicians' Desk Reference. 54th ed. Montvale, NJ Medical Economics Press2000;
TR Computer-based drug-utilization review. N Engl J Med.
1995;3331290- 1291Link to Article
DW Preventable medication errors: identifying and eliminating serious drug interactions [abstract]. J Am Pharm Assoc. 2001;41159- 160
M Pharmacies and prevention of potentially fatal drug interactions. JAMA.
1996;2751086- 1087Link to Article
DW Electronic point-of-care prescribing: writing the script. Dis Manage Health Outcomes.
2000;7297- 304Link to Article
TD Beyond structure-process-outcome: Donabedian's seven pillars and eleven buttresses of quality. Jt Comm J Qual Improv. 2001;27169- 174
C Report from HIMSS 2001: medical errors. Healthcare Informatics. April2001;20- 22
AD Pharmacogenetics and the practice of medicine. Nature.
2000;405857- 865Link to Article
AK Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet.
1999;353717- 719Link to Article
DA Phenytoin disposition and toxicity: role of pharmacogenetic and interethnic factors. Drug Metab Rev.
1995;27449- 469Link to Article